EUSA Pharma Competitors and Similar CompaniesClear all
EUSA Pharma's competitors and similar companies include Exscientia, Immunomedics, Ascentage Pharma and BioLineRx.
 Exscientia Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery. |  Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. |  Ascentage Pharma Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies. | |||
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 1982 | Founding Date 2017 | Founding Date 2003 |
Type | Type Private | Type Subsidiary | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Hemel Hempstead, GB HQ | Locations Oxford, GB HQ Wien, AT Osaka, JP Dundee, GB Miami, US | Locations Morris Plains, US HQ | Locations Suzhou, CN HQ Guangzhou Shi, CN Suzhou Shi, CN Taizhou, CN Rockville, US | Locations Modi'in-Maccabim-Re'ut, IL HQ |
Employees | Employees 965% decrease | Employees 88 | Employees 8914% decrease | Employees 567 | Employees 2414% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £20.1m (FY, 2023) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) ¥574.1m (FY, 2025) | Revenue (est.) $1.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods £10.5m (FY, 2023) | Cost of goods N/A | Cost of goods ¥48.9m (FY, 2025) | Cost of goods $230k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit £10.8m (FY, 2023) | Gross profit $295k (FY, 2019) | Gross profit ¥546.6m (FY, 2025) | Gross profit $950k (FY, 2025) |
Net income | Net income N/A | Net income (£146m) (FY, 2023) | Net income ($357.3m) (FY, 2019) | Net income (¥1.2b) (FY, 2025) | Net income ($2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 54.2m | Total funding raised $ 430.2m | Total funding raised $ 30m | Total funding raised $ 237.5m | Total funding raised $ 100.9m |
For sources of this data, please see the company profile
View Company Profiles
Exscientia
HQ
Oxford, GB
Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery.
View companyImmunomedics
HQ
Morris Plains, US
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View companyAscentage Pharma
HQ
Suzhou, CN
Employees
567
Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.
View company
BioLineRx
HQ
Modi'in-Maccabim-Re'ut, IL
Employees
24↓ 14% decrease
BioLineRx is a biopharmaceutical company focused on oncology.
View company